Liver disease in transplanted patients.
D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D004796:Clinical Enzyme Tests; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000209:etiology; D005260:Female; D006084:Graft Rejection; D006501:Hepatic Encephalopathy / Q000139:chemically induced / Q000209:etiology; D006505:Hepatitis / Q000150:complications / Q000276:immunology; D006511:Hepatitis B Antigens; D006801:Humans; D007165:Immunosuppression Therapy; D007565:Jaundice / Q000139:chemically induced / Q000209:etiology; D016030:Kidney Transplantation; D008107:Liver Diseases / Q000209:etiology*; D008111:Liver Function Tests; D008297:Male; D014184:Transplantation, Homologous
D006511:Hepatitis B Antigens; D001379:Azathioprine